Hide Board Information

Show Board Information

EuroDry Ltd. EDRY

Board Mod: Add me as mod

Asst Mods:

Last Post: 10/13/2023 2:00:49 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

EuroDry Ltd. (NASDAQ: EDRY) Stock Message Board

1. EDRY Company Profile

    

2. EDRY Time & Sales

    

3. EDRY Recent News

    

4. EDRY Filings

    

5. EDRY Financials

    

6. EDRY Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

6	$EDRY News Article - EuroDry Ltd. Announces	whytestocks	10/13/2023 2:00:49 PM
5	$EDRY News Article - EuroDry Ltd. To Participate	whytestocks	01/19/2022 3:25:50 PM
4	$EDRY News Article - Aristides Pittas Wins	whytestocks	12/08/2021 4:20:54 PM
3	$EDRY News Article - EuroDry Ltd. to Participate	whytestocks	03/15/2021 10:45:55 AM
2	$EDRY News Article - EuroDry Ltd. Sets Date for	whytestocks	02/11/2021 3:26:41 PM
1	EDRY 58% v15,6M c7.10 f2,3M preMH14.5 then	znewcar1	11/12/2020 8:58:12 PM

Recent Articles

• Kura Oncology's Upcoming Q2 2025 Financial Results Report
• Global Crossing Airlines: Upcoming Q2 Conference Call Details
• MariMed Expands Distribution of Medical Cannabis Products
• Flow Capital's Strategic Investment Fuels Common Wealth's Growth
• BriaCell Makes Progress with UCLA Health in Phase 3 Study
• Commerce.com Reports Strong Second Quarter Performance
• FOXO Technologies Expands Operations with License Renewal
• Alliant Credit Union Records Unprecedented Growth in Mortgages
• Key Insights and Speaker Highlights from the Asia Go IPO Summit
• Wayfair Expands Retail Presence with New Store in Denver
• Orrön Energy Sells 76 MW Solar Project, Expanding Green Portfolio
• Real Matters Delivers Strong Q3 Results Amid Market Changes
• International Paper's Latest Earnings Reveal Strategic Growth Plans
• CSW Industrials Breaks Records in First Quarter Financials
• XPO Logistics Reveals Strong Financial Performance in Q2
• Innovative Research Insights from the Alzheimer's Conference
• Gildan's Remarkable Revenue Growth and Adjusted EPS Performance
• Enlil Forms Partnerships to Transform MedTech and FDA Success
• ATCO Ltd. Reports Strong Q2 2025 Earnings with Growth
• Future of Finance: CFOs Embrace Cryptocurrency Strategies
• AMETEK Reflects Growth with Record Q2 Earnings Announcement
• Howmet Aerospace's Exciting Second Quarter 2025 Performance
• Quanta Services' Impressive Q2 2025 Earnings Insights
• Unveiling the 2025 Outlander Trail Edition: Adventure Awaits
• Transforming Transplantation: Buckeye and Afflo's Game-Changer
• Stagwell Inc. Sees Solid Revenue Growth in Latest Earnings
• S&P Global's Strong Second Quarter Financial Performance Revealed
• Bill Eager to Lead S&P Global Mobility as New President
• GreenHill Investment Reporting's Commitment to Excellence Shines
• Sound Blade Medical Names Neil Barman as New CEO
• Kimco Realty Reports Strong Q2 2025 Results with Increased Guidance
• CMG Expands Its Software Solutions with SeisWare Purchase
• Relmada Therapeutics Announces Q2 2025 Financial Results Call
• PyroGenesis Secures Major Titanium Powder Order from Europe
• Mastech Digital to Present Q2 Financial Outcomes Soon
• Lightspeed Commerce Reveals Impressive Q1 2026 Financials
• ISC Successfully Extends Credit Facility Until 2029
• BTCS Engages in Key Fireside Chat Discussion with Analysts
• Xanadu Mines Moves Toward Voluntary TSX Delisting Process
• Daisy Enhances Presence with Strategic Acquisition in Boston
• Medicenna Grants Five New Patents for IL-2 and IL-4 Innovations
• Mobilicom and ARK Electronics Unite for Innovative Drone Solutions
• Cartier Silver Corporation Completes Significant Acquisition
• Main Street Capital Invests in Leading Tax Collection Firm
• Audacity Capital Enhances Trading Experience with DXtrade Platform
• Signet Health Welcomes Joy Figarsky as New CEO to Drive Growth
• Hycroft Mining Corporation Details Growth and Future Prospects
• Arcadia Enhances Healthcare Data Access with New Strategies
• BioCryst Pharmaceuticals Welcomes Charlie Gayer as New CEO
• SiriusXM Unveils Impressive Q2 2025 Financial Performance